問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberT1219
Completed

2019-12-01 - 2022-12-31

Phase II

Recruiting7

ICD-10C24.8

Malignant neoplasm of overlapping sites of biliary tract

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9156.8

Malignant neoplasm of other specified sites of gallbladder and extrahepatic bile ducts

  • Trial Applicant

    National Health Research Institutes

  • Sponsor

  • Trial scale

    Taiwan Multiple Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Yan-Shen Shan Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Jen-Shi Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming-Huang Chen Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Li-Yuan Bai Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Li-Tzong Chen Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator TSUNG-HAO LIU Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    48 participants

  • Global

    48 participants